RXST logo

RxSight (RXST) EBITDA

Annual EBITDA

-$41.04 M
+$16.74 M+28.98%

December 31, 2023

Summary

Performance

1-Year Change

+28.98%

3-Year Change

-227.63%

5-Year Change

-131.52%

15-Year Change

-131.52%

RXST EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.77%
RXST annual EBITDA is higher than 36.77% of companies in Healthcare sector

High & Low

All-time High

$130.20 M
RXST annual EBITDA is currently -131.52% below its historical high of $130.20 million

3-Year Low

-$57.78 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RXST previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
RXST next annual earnings announcement is scheduled for Feb 28, 2025

OtherRXSTprofitabilitymetrics:

Annual Revenue

$89.08 M
RXST annual revenue is $89.08 million

Annual Net Income

-$48.61 M
RXST annual net profit is -$48.61 million

Annual EBIT

-$45.28 M
RXST annual earnings before interest & taxes is -$45.28 million

Annual EPS

-$1.41
RXST annual earnings per share is -$1.41

Quarterly EBITDA

-$5.18 M
+$58.00 K+1.11%

September 30, 2024

Summary

Performance

3-Month Change

+1.11%

1-Year Change

+36.12%

3-Year Change

+36.12%

5-Year Change

+36.12%

RXST Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.95%
RXST quarterly EBITDA is higher than 46.95% of companies in Healthcare sector

High & Low

All-time High

$31.75 M
RXST quarterly EBITDA is currently -116.31% below its historical high of $31.75 million

3-Year Low

-$15.50 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RXST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RXST next earnings announcement is scheduled for Feb 28, 2025

OtherRXSTprofitabilitymetrics:

Quarterly Revenue

$35.31 M
RXST quarterly revenue is $35.31 million

Quarterly Net Income

-$6.34 M
RXST quarterly net profit is -$6.34 million

Quarterly EBIT

-$6.32 M
RXST quarterly earnings before interest & taxes is -$6.32 million

Quarterly EPS

-$0.16
RXST quarterly earnings per share is -$0.16

TTM EBITDA

-$26.47 M
+$5.86 M+18.14%

September 30, 2024

Summary

Performance

3-Month Change

+18.14%

1-Year Change

+35.5%

3-Year Change

+35.5%

5-Year Change

+35.5%

RXST TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.32%
RXST TTM EBITDA is higher than 44.32% of companies in Healthcare sector

High & Low

All-time High

$42.76 M
RXST TTM EBITDA is currently -161.90% below its historical high of $42.76 million

3-Year Low

-$58.22 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RXST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RXST next earnings announcement is scheduled for Feb 28, 2025

OtherRXSTprofitabilitymetrics:

TTM Revenue

$128.29 M
RXST TTM revenue is $128.29 million

TTM Net Income

-$30.69 M
RXST TTM net profit is -$30.69 million

TTM EBIT

-$30.65 M
RXST TTM earnings before interest & taxes is -$30.65 million

TTM EPS

-$0.82
RXST TTM earnings per share is -$0.82

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$41.04 M
RXST annual EBITDA is -$41.04 million

Annual Net Income

-$48.61 M
RXST annual net profit is -$48.61 million

Annual Interest Expense

$3.31 M
RXST annual interest expense is $3.31 million

Annual Income Tax

$20.00 K
RXST annual income tax is $20.00 thousand

Annual D&A

$4.24 M
RXST annual depreciation & amortization is $4.24 million

RXST EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.0%+36.1%+35.5%
3 y3 years-227.6%+36.1%+35.5%
5 y5 years-131.5%+36.1%+35.5%

RXST EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.1%+29.0%at high+66.6%at high+54.5%
5 y5-year-131.5%+29.0%-116.3%+66.7%-161.9%+54.5%
alltimeall time-131.5%+29.0%-116.3%+66.7%-161.9%+54.5%

RxSight EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.18 M(-1.1%)
-$26.47 M(-18.1%)
Jun 2024
-
-$5.24 M(-34.1%)
-$32.33 M(-15.5%)
Mar 2024
-
-$7.95 M(-2.0%)
-$38.27 M(-6.7%)
Dec 2023
-$41.04 M(-29.0%)
-$8.11 M(-26.6%)
-$41.04 M(-11.0%)
Sep 2023
-
-$11.04 M(-1.2%)
-$46.12 M(-7.0%)
Jun 2023
-
-$11.18 M(+4.4%)
-$49.62 M(-6.4%)
Mar 2023
-
-$10.71 M(-18.9%)
-$52.99 M(-8.3%)
Dec 2022
-$57.78 M
-$13.19 M(-9.3%)
-$57.78 M(-0.8%)
Sep 2022
-
-$14.54 M(-0.1%)
-$58.22 M(+7.3%)
Jun 2022
-
-$14.55 M(-6.1%)
-$54.27 M(+5.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$15.50 M(+13.7%)
-$51.37 M(+25.3%)
Dec 2021
-$41.01 M(-227.5%)
-$13.63 M(+28.8%)
-$41.01 M(<-9900.0%)
Sep 2021
-
-$10.59 M(-9.2%)
$415.00 K(-99.0%)
Jun 2021
-
-$11.65 M(+127.0%)
$42.76 M(+0.5%)
Mar 2021
-
-$5.13 M(-118.5%)
$42.56 M(+32.4%)
Dec 2020
$32.15 M(-75.3%)
$27.79 M(-12.5%)
$32.15 M(+637.1%)
Sep 2020
-
$31.75 M(-367.9%)
$4.36 M(-115.9%)
Jun 2020
-
-$11.85 M(-23.7%)
-$27.39 M(+76.3%)
Mar 2020
-
-$15.54 M
-$15.54 M
Dec 2019
$130.20 M
-
-

FAQ

  • What is RxSight annual EBITDA?
  • What is the all time high annual EBITDA for RxSight?
  • What is RxSight annual EBITDA year-on-year change?
  • What is RxSight quarterly EBITDA?
  • What is the all time high quarterly EBITDA for RxSight?
  • What is RxSight quarterly EBITDA year-on-year change?
  • What is RxSight TTM EBITDA?
  • What is the all time high TTM EBITDA for RxSight?
  • What is RxSight TTM EBITDA year-on-year change?

What is RxSight annual EBITDA?

The current annual EBITDA of RXST is -$41.04 M

What is the all time high annual EBITDA for RxSight?

RxSight all-time high annual EBITDA is $130.20 M

What is RxSight annual EBITDA year-on-year change?

Over the past year, RXST annual EBITDA has changed by +$16.74 M (+28.98%)

What is RxSight quarterly EBITDA?

The current quarterly EBITDA of RXST is -$5.18 M

What is the all time high quarterly EBITDA for RxSight?

RxSight all-time high quarterly EBITDA is $31.75 M

What is RxSight quarterly EBITDA year-on-year change?

Over the past year, RXST quarterly EBITDA has changed by +$2.93 M (+36.12%)

What is RxSight TTM EBITDA?

The current TTM EBITDA of RXST is -$26.47 M

What is the all time high TTM EBITDA for RxSight?

RxSight all-time high TTM EBITDA is $42.76 M

What is RxSight TTM EBITDA year-on-year change?

Over the past year, RXST TTM EBITDA has changed by +$14.57 M (+35.50%)